---
title: "NLRP3"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene: NLRP3"
tags: ['NLRP3', 'AutoinflammatoryDiseases', 'Inflammasome', 'Interleukin1Inhibitors', 'CAPS', 'MWS', 'FCAS', 'GeneticMutations']
---

# Gene: NLRP3

## Genetic Position
The NLRP3 gene is located on chromosome 1 at 1q44.

## Pathology and Function
The NLRP3 gene is also known as NALP3, cryopyrin, or NLR family, pyrin domain containing 3. It encodes a protein that is a component of the inflammasome, which regulates the immune response to infection and inflammation. Mutations in NLRP3 have been associated with various autoinflammatory diseases, including cryopyrin-associated periodic syndromes (CAPS). 

## External IDs and Aliases
- HGNC:7468
- NCBI Entrez:114548
- Ensembl:ENSG00000162714
- OMIM:606416
- UniProtKB/Swiss-Prot: Q96P20

## AA Mutation List and Mutation Type with dbSNP ID
- rs35829419 (p.A441V)
- rs61731956 (p.V198M)
- rs121918626 (p.V225A)
- rs121918627 (p.G569R)
- rs147263882 (p.T350M)
- rs121918629 (p.T120R)
- rs121918631 (p.G755E)

## Somatic SNVs/InDels with dbSNP ID
There are currently no reported somatic mutations in NLRP3.

## Related Disease
NLRP3 mutations have been associated with various autoinflammatory diseases, including:
- Cryopyrin-associated periodic syndromes (CAPS)
- Muckle-Wells syndrome (MWS)
- Familial cold autoinflammatory syndrome (FCAS)

## Treatment and Prognosis
The treatment for NLRP3-associated diseases typically involves the use of interleukin-1 inhibitors, such as anakinra or canakinumab. The prognosis for patients with NLRP3 mutations varies depending on the specific disease and severity.

## Drug Response
Patients with NLRP3 mutations, particularly those with CAPS, have shown significant improvement with the use of interleukin-1 inhibitors.

## Related Papers
- Author: Lachmann HJ, Lowe P, Felix SD, et al.
  - Title: In vivo regulation of interleukin 1Î² in patients with cryopyrin-associated periodic syndromes.
  - DOI: 10.1086/651559
- Author: Kuemmel A, Dalpke A, Dittmar M, et al.
  - Title: Cryopyrin-associated periodic syndromes: clinical features and molecular mechanisms.
  - DOI: 10.2147/JAA.S31943
- Author: Aksentijevich I, Masters SL, Ferguson PJ, et al.
  - Title: An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.
  - DOI: 10.1056/NEJMoa020988

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**